Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

D. C. Brennan; K. A. Garlock; B. J. Lippmann; R. S. Buller; M. Gaudreault-Keener; U. A. Lowell; S. B. Miller; S. Shenoy; T. K. Howard; G. A. Storch

doi:10.1016/S0041-1345(96)00143-1

Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

D. C. Brennan, K. A. Garlock, B. J. Lippmann, R. S. Buller, M. Gaudreault-Keener, U. A. Lowell, S. B. Miller, S. Shenoy, T. K. Howard, G. A. Storch

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	809-811
Number of pages	3
Journal	Transplantation proceedings
Volume	29
Issue number	1-2
DOIs	https://doi.org/10.1016/S0041-1345(96)00143-1
State	Published - 1997
Externally published	Yes

ASJC Scopus subject areas

Surgery
Transplantation

Access to Document

10.1016/S0041-1345(96)00143-1

Cite this

Brennan, D. C., Garlock, K. A., Lippmann, B. J., Buller, R. S., Gaudreault-Keener, M., Lowell, U. A., Miller, S. B., Shenoy, S., Howard, T. K., & Storch, G. A. (1997). Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients. Transplantation proceedings, 29(1-2), 809-811. https://doi.org/10.1016/S0041-1345(96)00143-1

Brennan, DC, Garlock, KA, Lippmann, BJ, Buller, RS, Gaudreault-Keener, M, Lowell, UA, Miller, SB, Shenoy, S, Howard, TK & Storch, GA 1997, 'Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients', Transplantation proceedings, vol. 29, no. 1-2, pp. 809-811. https://doi.org/10.1016/S0041-1345(96)00143-1

@article{a71fee50dc5e4190bfa46749ddc1bfb8,

title = "Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients",

author = "Brennan, {D. C.} and Garlock, {K. A.} and Lippmann, {B. J.} and Buller, {R. S.} and M. Gaudreault-Keener and Lowell, {U. A.} and Miller, {S. B.} and S. Shenoy and Howard, {T. K.} and Storch, {G. A.}",

note = "Funding Information: From the Washington University School of Medicine and Barnes Hospital, St. Louis, Missouri. The work was supported in part by a grant from the Missouri Kidney Program. Address reprint requests to Daniel C. Brennan, MD, FACP, Director, Transplant Nephrology, 6107 Queeny Tower, One Barnes Hospital Plaza, St. Louis, MO 63110.",

year = "1997",

doi = "10.1016/S0041-1345(96)00143-1",

language = "English (US)",

volume = "29",

pages = "809--811",

journal = "Transplantation proceedings",

issn = "0041-1345",

publisher = "Elsevier USA",

number = "1-2",

}

TY - JOUR

T1 - Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

AU - Brennan, D. C.

AU - Garlock, K. A.

AU - Lippmann, B. J.

AU - Buller, R. S.

AU - Gaudreault-Keener, M.

AU - Lowell, U. A.

AU - Miller, S. B.

AU - Shenoy, S.

AU - Howard, T. K.

AU - Storch, G. A.

N1 - Funding Information: From the Washington University School of Medicine and Barnes Hospital, St. Louis, Missouri. The work was supported in part by a grant from the Missouri Kidney Program. Address reprint requests to Daniel C. Brennan, MD, FACP, Director, Transplant Nephrology, 6107 Queeny Tower, One Barnes Hospital Plaza, St. Louis, MO 63110.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=12644276434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644276434&partnerID=8YFLogxK

U2 - 10.1016/S0041-1345(96)00143-1

DO - 10.1016/S0041-1345(96)00143-1

M3 - Article

C2 - 9123536

AN - SCOPUS:12644276434

SN - 0041-1345

VL - 29

SP - 809

EP - 811

JO - Transplantation proceedings

JF - Transplantation proceedings

IS - 1-2

ER -

Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this